REUTERS - Ranbaxy Laboratories Ltd (RANB.NS), India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.
The drug is in-licensed from Cipher Pharmaceuticals Inc DND.TO, said Ranbaxy, controlled by Japan's Daiichi Sankyo Co (4568.T), on Monday. (Reporting by Kaustubh Kulkarni in Mumbai)
Trending On Reuters
India has waived retrospective imposition of a minimum alternative tax (MAT) affecting foreign funds, the Finance Minister said on Tuesday, a move that could resolve a dispute that had shaken investor confidence. Full Article